# FDA Inspection 1254934 - Bioreliance Corporation - November 22, 2024

Source: https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/effdc699-9dd4-4d58-b3a7-1c5bf7d6db8d
Source feed: FDA_Inspections

> FDA Inspection 1254934 for Bioreliance Corporation on November 22, 2024. Classification: Voluntary Action Indicated (VAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1254934
- Company Name: Bioreliance Corporation
- Inspection Date: 2024-11-22
- Classification: Voluntary Action Indicated (VAI)
- Project Area: Vaccines and Allergenic Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1295306 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/e199758b-3727-437f-82a7-ea444bde9780)
- [FDA Inspection 1295306 - 2026-01-29](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/32d260b4-d28e-448b-869c-0c4ee6dba43c)
- [FDA Inspection 1254934 - 2024-11-22](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/7941bc6b-db19-4266-b05d-af8a19fbde51)
- [FDA Inspection 1215040 - 2023-08-04](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/89149f6b-0201-4f3c-9500-60de669dfba4)
- [FDA Inspection 1059115 - 2018-07-13](https://www.keypedia.com/records/fda_inspections/bioreliance-corporation/0f6693b3-da19-4b48-baba-44ef49d485ab)

Company: https://www.keypedia.com/companies/bioreliance-corporation/08d3dc20-6c7e-4f04-bb98-bbc868e70000

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d